Mutational Landscape of Lethal Castrate Resistant Prostate Cancer

ERG - ERG gene rearrangement in tumor (phv00181107.v1.p1)
ETV1 - ETV1 gene rearrangement in tumor (phv00181108.v1.p1)
RAF/RAS - RAF/RAS family gene rearrangement tumor (phv00181110.v1.p1)
SPINK1 - SPINK1 gene outlier over-expression in tumor (phv00181109.v1.p1)
SURVIVAL_C - Survival (in months) after first chemotherapy (phv00181124.v1.p1)
SURVIVAL_DX - Survival (in months) after diagnosis (phv00181122.v1.p1)
SURVIVAL_H - Survival (in months) after first hormone therapy (phv00181123.v1.p1)
TUMOR_GLEASON_SCORE - Tumor Gleason score of sample (phv00181119.v1.p1)
TUMOR_TREATMENT - Type(s) of tumor treatment for sample (phv00181121.v1.p1)

ANALYTE_TYPE - Analyte type (phv00181115.v1.p1)
BODY_SITE - Body site where sample was collected (phv00181114.v1.p1)
CONSENT - Consent group as determined by DAC (phv00181097.v1.p1)
GEO_ACCESSION - GEO accession ID (phv00181112.v1.p1)
HISTOLOGICAL TYPE - Cell or tissue type or subtype of sample (phv00181117.v1.p1)
IS_TUMOR - Tumor status (phv00181116.v1.p1)
PRIMARY_METASTATIC_TUMOR - Primary tumor or metastasis (phv00181118.v1.p1)
SAMPLE_ALIAS - Alias name to sample (phv00181125.v1.p1)
SAMPLE_ID - De-identified sample ID (phv00181113.v1.p1)
SAMPLE_ID - Sample ID (phv00181101.v1.p1)
SAMPLE_ID - Sample ID (phv00181111.v1.p1)
SAMPLE_SOURCE - Source repository where samples originate (phv00181102.v1.p1)
SAMPLE_USE - Sample Use (phv00181104.v1.p1)
SERUM_PSA - Serum PSA at diagnosis (untreated tumors) or death (treated tumors) (phv00181120.v1.p1)
SOURCE_SAMPLE_ID - Sample ID used in the Source Repository (phv00181103.v1.p1)
SOURCE_SUBJECT_ID - Subject ID used in the Source Repository (phv00181099.v1.p1)
SUBJECT_ID - De-identified subject ID (phv00181105.v1.p1)
SUBJECT_ID - Subject ID (phv00181100.v1.p1)
SUBJECT_ID - Subject ID (phv00181096.v1.p1)
SUBJECT_SOURCE - Source repository where subjects originate (phv00181098.v1.p1)